Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PALI

PALISADE BIO, INC.

CIK 0001357459 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$2.10
↑ 0.04 (1.94%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$365.97M
P/E Ratio
-11.46
EPS
-0.30
Dividend Yield
Not covered
52W Position
68%
Beta
1.31

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
3.01
P/S
731.94
EV/Revenue
481.59
ROE
-26.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 68%
$0.53$2.85

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$16.78M
Total Assets
$134.34M
Free Cash Flow
–

Recent news